UBS analyst Radi Sultan lowered the firm’s price target on Confluent (CFLT) to $30 from $38 and keeps a Buy rating on the shares. Confluent shares were down following the lowered 2025 growth outlook, with the company citing macro driving an uptick in optimizations and slower use case adds in the larger customer base, the analyst tells investors in a research note. UBS argues that Confluent may be sitting in front of a real product cycle between Tableflow, Flink, and WarpStream, which could drive material incremental growth.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CFLT:
- Confluent price target lowered to $32 from $40 at Piper Sandler
- Confluent’s Strong Q1 Performance and Strategic Positioning Justify Buy Rating
- Confluent price target lowered to $32 from $38 at Canaccord
- Confluent price target lowered to $31 from $38 at Guggenheim
- Confluent’s Strong Performance and Growth Potential Justifies Buy Rating Despite Adjusted Guidance
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue